Assignee
THE MEDICINES CO
US·7 granted patents·3 pending applications·27 citations·filing 2013–2017
Top patents by PatentIndex Score
10 records- 0193US9427448B2Methods of treating, reducing the incidence of, and/or preventing ischemic eventsTHE MEDICINES CO·Filed 2013·Granted Aug 30, 2016·14 cites·14 claims
- 0290US10376532B2Methods of treating, reducing the incidence of, and/or preventing ischemic eventsTHE MEDICINES CO·Filed 2013·Granted Aug 13, 2019·7 cites·17 claims
- 0383US9439921B2Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the sameTHE MEDICINES CO·Filed 2016·Granted Sep 13, 2016·4 cites·26 claims
- 0471US9775878B2Methods for treating bacterial infections using oritavancin and polymyxinsTHE MEDICINES CO·Filed 2014·Granted Oct 3, 2017·2 cites·19 claims
- 0552US10328118B2High purity oritavancin and method of producing sameTHE MEDICINES CO·Filed 2017·Granted Jun 25, 2019·0 cites·10 claims
- 0650US9649352B2High purity oritavancin and method of producing sameTHE MEDICINES CO·Filed 2015·Granted May 16, 2017·0 cites·15 claims
- 0747US12514899B2Methods of treatment using single doses of oritavancinTHE MEDICINES CO·Filed 2013·Granted Jan 6, 2026·0 cites·7 claims
- 0847US2018104360A1Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Protein ReductionTHE MEDICINES CO·Filed 2017·Application pending·0 cites
- 0942US2017224662A1Aqueous Formulations and Methods of Preparation and Use ThereofTHE MEDICINES CO·Filed 2017·Application pending·0 cites
- 1035US2017239323A1Oritavancin formulationsTHE MEDICINES CO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when THE MEDICINES CO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →